Add BrightSurf on Google Email

Michigan Medicine - University of Michigan


Waiting for a bed, but not for care: Emergency department boarding study finds wide variation in handoffs

A new study found that 23% of emergency department boarding patients wait at least 4 hours before receiving inpatient-quality care, with some patients waiting 12 or 24 hours. The study highlights the importance of efficient handoffs from emergency to inpatient care, particularly for vulnerable populations.

SourceMichigan Medicine - University of Michigan·JournalJAMA·TypeData/statistical analysis·DateAug 17, 2026

More leucovorin prescribed to children after federal officials touted its unproven benefits for autism

A study found a sharp increase in leucovorin dispensing to children aged 0-17 after a press conference touting its autism benefits, despite limited evidence supporting the claim. The spike in prescriptions rose 700% between 2024 and 2025, with the largest increases seen among children ages 6-11 and in the southern US.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·DateAug 12, 2026

Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy

A new study examines the KEYNOTE-689 trial cohort to determine whether anticipated survival benefits outweigh the costs based on a standard threshold. Patients with higher combined positive scores saw significant quality-adjusted life years gains with perioperative pembrolizumab.

SourceMichigan Medicine - University of Michigan·JournalJAMA Otolaryngology–Head & Neck Surgery·TypeData/statistical analysis·DateAug 10, 2026

Heart failure ‘polypill’ improves cardiac function, cuts hospitalization risk

A study published in Nature Medicine found that a single daily dose of a polypill significantly enhances cardiac function and reduces hospitalizations for patients with heart failure. The treatment, which combines three types of medications, shows promise as a simplified approach to optimal therapy.

SourceMichigan Medicine - University of Michigan·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJul 20, 2026

Drug candidate treats severe fatty liver disease by protecting the gut in animal models

Researchers discovered a potential drug developed at Michigan Medicine reverses metabolic dysfunction-associated steatohepatitis (MASH) in animal models by disrupting the disease-driving pathway that links the gut and liver. DT-109 improved gut health, reducing inflammation in livers of nonhuman primates.

SourceMichigan Medicine - University of Michigan·JournalJournal of Clinical Investigation·TypeExperimental study·DateJul 7, 2026

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication

Researchers at University of Michigan Health have implanted the first wireless brain-computer interface (BCI) to restore communication in a patient with motor neuron disease. The study, called Connect-One Early Feasibility Study, aims to assess the device's long-term safety and effectiveness in synthesizing text and speech.

SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026

University of Michigan implants first-in-human Paradromics wireless brain-computer interface, designed to restore communication

The University of Michigan has successfully implanted the first-in-human Paradromics wireless brain-computer interface, designed to restore communication for patients with difficulty speaking. The clinical trial will focus on the device's long-term safety and assess its ability to restore communication through synthesized text and speech.

SourceMichigan Medicine - University of Michigan·TypeExperimental study·DateJun 17, 2026

U-M hepatologist hails hepatitis B treatment trial results

Researchers have announced promising results of the B-Well clinical trials, showing that 20% and 19% of patients achieved a functional cure for their chronic hepatitis B infections after 24 weeks of bepirovirsen treatment. This represents a significant step towards developing a curative treatment for the disease.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·TypeCommentary/editorial·DateMay 28, 2026

Study sheds light on how early pancreas lesions become cancerous

Researchers have discovered that precursor lesions in the pancreas, often considered a step towards cancer, do not undergo malignant transformation if they lack a specific microenvironment. The team used advanced technologies to isolate and analyze single cells from over 150 donated pancreases, finding that the microenvironment surroun...

SourceMichigan Medicine - University of Michigan·JournalCancer Discovery·TypeExperimental study·DateMay 21, 2026

New study finds Rx kids associated with significant reductions in infant maltreatment investigations

A new peer-reviewed study found that Michigan State University's Rx Kids program is associated with substantial reductions in child maltreatment investigations among infants. The program provided early economic support to families, leading to a 7-percentage-point decline or 32% relative reduction in maltreatment investigations.

SourceMichigan Medicine - University of Michigan·JournalJAMA Pediatrics·TypeData/statistical analysis·DateMay 7, 2026

Study suggests fibroid rates in Latina women may be lower than previously thought

A new study published in the American Journal of Obstetrics and Gynecology finds that approximately 11.8% of reproductive-age Latina women have fibroids, lower than previously estimated rates. The study, led by Michigan Medicine researchers, used ultrasound-confirmed diagnoses to confirm fibroid cases.

SourceMichigan Medicine - University of Michigan·JournalAmerican Journal of Obstetrics and Gynecology·DateApr 27, 2026

Medicaid expansion helped enrollees’ long-term financial health, study finds

A new study found that Michigan Medicaid expansion helped enrollees significantly reduce their medical debt in collections by up to 75% within seven years of enrollment. Additionally, the study shows substantial drops in sub-prime credit scores, improving financial stability and long-term health outcomes.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeData/statistical analysis·DateApr 27, 2026

IBS treatment response predicted by gut microbiome in new study

Researchers found distinct gut microbiome characteristics that predicted treatment response to the low FODMAP diet and rifaximin. Patients who responded to these treatments had different microbial signatures, with increases in diversity for those on the low FODMAP diet and resilience against antibiotics for those on rifaximin.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Pregnancy-related deaths rose during pandemic, remain elevated for Black women, study finds

A new study found that pregnancy-related deaths increased sharply during the pandemic, particularly among Black women, but rates have since returned to pre-pandemic levels for most groups. However, disparities persist, especially in later postpartum deaths, which remain elevated for non-Hispanic Black mothers.

SourceMichigan Medicine - University of Michigan·JournalObstetrics and Gynecology·DateApr 14, 2026

New study hints at the cause of a painful skin condition—and at a long-awaited potential treatment

A new University of Michigan-led research has identified a connection between keratin 16 and type 1 interferon in the molecular pathways of pachyonychia congenita. The study found that losing or altering K16 causes amplification of the inflammatory response, but also helps pump the brakes on that response.

SourceMichigan Medicine - University of Michigan·JournalScience Translational Medicine·TypeExperimental study·DateApr 13, 2026

Researchers identify new therapeutic target for neuroendocrine tumors in the gastrointestinal tract

A new study identified PIKfyve as a promising therapeutic target for gastroenteropancreatic neuroendocrine tumors (GEP-NETs), leading to longer survival in mouse models. By targeting two separate pathways that control lipid synthesis, the researchers found that inhibiting PIKfyve reduced tumor volume and weight compared to controls.

SourceMichigan Medicine - University of Michigan·JournalCell Reports Medicine·TypeExperimental study·DateApr 6, 2026

Thoughts don’t kill people, but study suggests options for keeping guns from doing so

A new study from Michigan Medicine found that over 7% of Americans have thought about shooting someone, while 8.7 million adults considered it in the last year. Firearm owners were no more likely to have these thoughts than non-owners, but 21% of those who had thoughts said they would consider giving their gun to someone for safekeeping.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeSurvey·DateMar 17, 2026

Half of newborns with severe spina bifida have trouble breathing during sleep

Researchers discovered that 53% of newborns with myelomeningocele had sleep-disordered breathing, highlighting the need for routine screening and early intervention to prevent long-term complications. The study's findings suggest that addressing sleep disorders in high-risk infants could meaningfully improve their neurodevelopment.

SourceMichigan Medicine - University of Michigan·JournalPEDIATRICS·TypeObservational study·DateMar 5, 2026